Purpose: This study focuses on stop voicing differentiation in bilingual children with normal hearing (NH) and their bilingual peers with hearing loss who use cochlear implants (CIs). Method: Twenty-two bilingual children participated in our study (11 with NH, M age = 5;1 [years;months], and 11 with CIs, M hearing age = 5;1). The groups were matched on hearing age and a range of demographic variables. Single-word picture elicitation was used with word-initial singleton stop consonants. Repeated measures analyses of variance with three within-subject factors (language, stop voicing, and stop place of articulation) and one between-subjects factor (NH vs. CI user) were conducted with voice onset time and percentage of prevoiced stops as dependent variables. Results: Main effects were statistically significant for language, stop voicing, and stop place of articulation on both voice onset time and prevoicing. There were no significant main effects for NH versus CI groups. Both children with NH and with CIs differentiated stop voicing in their languages and by stop place of articulation. Stop voicing differentiation was commensurate across the groups of children with NH versus CIs. Conclusions: Stop voicing differentiation is accomplished in a similar fashion by bilingual children with NH and CIs, and both groups differentiate stop voicing in a languagespecific fashion.

No abstract

A growing number of people are living with cancer and dementia, creating a particular set of challenges and care needs in relation to their cancer treatment and care. These challenges exist across the cancer care pathway, from diagnosis through to decision-making, accessing treatment and care, and post-treatment, often resulting in a need for extensive support from families and further difficulties for those without familial support. This article summarises the challenges that arise when providing cancer treatment and care for people with dementia and identifies researchbased recommendations for tackling these challenges.

No abstract